October 2025, Vol 15, No 10

Drug shortages are reshaping cancer care – how can oncologists and cancer centers prepare and what do these gaps mean for treatment decisions, access, and affordability? Read More ›

In honor of Breast Cancer Awareness Month, we explore the growing role of AI in breast cancer screenings. Read More ›

This device produces a 5-year risk score that is intended to complement current protocol of radiologists’ reviews. Read More ›

A look at the essential leadership skills that can help organizations navigate crises, adapt to uncertainty, and emerge stronger from adversity. Read More ›

Only 19% of women said a healthcare provider had discussed nutrition’s role in breast cancer risk in a new Physicians Committee for Responsible Medicine/Morning Consult survey. Read More ›

It’s Breast Cancer Awareness Month, and officials with the Department of Veterans Affairs (VA) are encouraging patients to be screened and perform regular self-checks. Read More ›

World Conference on Lung Cancer research spotlights the success of the Reporting and Data System (RADS) screening initiative. Read More ›

This study underscores the need to reassess the role of legacy therapies in modern combination treatment regimens. Read More ›

Low-grade prostate cancer isn’t always low risk; factoring in all data reveals some patients may be undertreated. Read More ›

A look at estimates of life expectancy in prostate cancer compared with other causes, using advanced statistical modeling. Read More ›

Researchers from the Fralin Biomedical Research Institute (Virginia Tech) Cancer Research Center in Washington, DC, have identified a group of cells called macrophages that, instead of protecting the body, appear to shield tumors from attack and promote tumor metastasis. Read More ›

A newly identified gene can be indirectly targeted with an existing class of drugs, suggesting a potential treatment strategy. Read More ›